Cargando…
Could Dermaseptin Analogue be a Competitive Inhibitor for ACE2 Towards Binding with Viral Spike Protein Causing COVID19?: Computational Investigation
Initial phase of COVID-19 infection is associated with the binding of viral spike protein S1 receptor binding domain (RBD) with the host cell surface receptor, ACE2. Peptide inhibitors typically interact with spike proteins in order to block its interaction with ACE2, and this knowledge would promot...
Autores principales: | Sekar, P. Chandra, Rajasekaran, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811342/ https://www.ncbi.nlm.nih.gov/pubmed/33488318 http://dx.doi.org/10.1007/s10989-020-10149-w |
Ejemplares similares
-
Probing the competitive inhibitor efficacy of frog-skin alpha helical AMPs identified against ACE2 binding to SARS-CoV-2 S1 spike protein as therapeutic scaffold to prevent COVID-19
por: Sekar, P. Chandra, et al.
Publicado: (2022) -
Biophysical Investigation of the Membrane-Disrupting Mechanism of the Antimicrobial and Amyloid-Like Peptide Dermaseptin S9
por: Caillon, Lucie, et al.
Publicado: (2013) -
Antitumor and Angiostatic Activities of the Antimicrobial Peptide Dermaseptin B2
por: van Zoggel, Hanneke, et al.
Publicado: (2012) -
Biological Activities of Cationicity-Enhanced and Hydrophobicity-Optimized Analogues of an Antimicrobial Peptide, Dermaseptin-PS3, from the Skin Secretion of Phyllomedusa sauvagii
por: Tan, Yining, et al.
Publicado: (2018) -
Discovery of two skin-derived dermaseptins and design of a TAT-fusion analogue with broad-spectrum antimicrobial activity and low cytotoxicity on healthy cells
por: Zhu, Haohao, et al.
Publicado: (2018)